These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25176034)

  • 1. Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition.
    Sheik-Khalil E; Bray MA; Özkaya Şahin G; Scarlatti G; Jansson M; Carpenter AE; Fenyö EM
    BMC Infect Dis; 2014 Aug; 14():472. PubMed ID: 25176034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new cell line-based neutralization assay for primary HIV type 1 isolates.
    Shi Y; Albert J; Francis G; Holmes H; Fenyö EM
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):957-67. PubMed ID: 12230938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging.
    Wen Z; Citron M; Bett AJ; Espeseth AS; Vora KA; Zhang L; DiStefano DJ
    J Virol Methods; 2019 Jan; 263():88-95. PubMed ID: 30381239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus.
    Katzelnick LC; Coello Escoto A; McElvany BD; Chávez C; Salje H; Luo W; Rodriguez-Barraquer I; Jarman R; Durbin AP; Diehl SA; Smith DJ; Whitehead SS; Cummings DAT
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006862. PubMed ID: 30356267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells.
    Zhou JY; Montefiori DC
    J Virol; 1997 Mar; 71(3):2512-7. PubMed ID: 9032392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV sensitivity to neutralization is determined by target and virus producer cell properties.
    Mann AM; Rusert P; Berlinger L; Kuster H; Günthard HF; Trkola A
    AIDS; 2009 Aug; 23(13):1659-67. PubMed ID: 19581791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of an HIV-1 transfection-neutralization assay.
    Back NK; Smit L; Hogervorst E; van Wijk AC; Goudsmit J; Tersmette M
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):531-8. PubMed ID: 7513760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
    Polonis VR; Brown BK; Rosa Borges A; Zolla-Pazner S; Dimitrov DS; Zhang MY; Barnett SW; Ruprecht RM; Scarlatti G; Fenyö EM; Montefiori DC; McCutchan FE; Michael NL
    Virology; 2008 Jun; 375(2):315-20. PubMed ID: 18367229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting.
    van Remmerden Y; Xu F; van Eldik M; Heldens JG; Huisman W; Widjojoatmodjo MN
    Virol J; 2012 Oct; 9():253. PubMed ID: 23114196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.
    Chenine AL; Wieczorek L; Sanders-Buell E; Wesberry M; Towle T; Pillis DM; Molnar S; McLinden R; Edmonds T; Hirsch I; O'Connell R; McCutchan FE; Montefiori DC; Ochsenbauer C; Kappes JC; Kim JH; Polonis VR; Tovanabutra S
    PLoS One; 2013; 8(11):e76104. PubMed ID: 24312165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.
    Sarzotti-Kelsoe M; Daniell X; Todd CA; Bilska M; Martelli A; LaBranche C; Perez LG; Ochsenbauer C; Kappes JC; Rountree W; Denny TN; Montefiori DC
    J Immunol Methods; 2014 Jul; 409():147-60. PubMed ID: 24607608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA; Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
    Sarzotti-Kelsoe M; Bailer RT; Turk E; Lin CL; Bilska M; Greene KM; Gao H; Todd CA; Ozaki DA; Seaman MS; Mascola JR; Montefiori DC
    J Immunol Methods; 2014 Jul; 409():131-46. PubMed ID: 24291345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.
    Lathey JL; Pratt RD; Spector SA
    J Infect Dis; 1997 Jan; 175(1):231-2. PubMed ID: 8985228
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis.
    Zielinska E; Liu D; Wu HY; Quiroz J; Rappaport R; Yang DP
    Virol J; 2005 Nov; 2():84. PubMed ID: 16281972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for the detection of virus infectivity in single cells and real time: Towards an automated fluorescence neutralization test.
    Maistriau M; Carletti T; Zakaria MK; Braga L; Faoro V; Vasileiadis V; Marcello A
    Virus Res; 2017 Jun; 237():1-6. PubMed ID: 28501626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR.
    Behrendt R; Fiebig U; Norley S; Gürtler L; Kurth R; Denner J
    J Virol Methods; 2009 Jul; 159(1):40-6. PubMed ID: 19442843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization.
    McInerney TL; Dimmock NJ
    AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1645-54. PubMed ID: 11779352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.